Publication | Closed Access

Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors

Cell TherapyTransplantationMarrow TransplantationStem Cell TransplantationImmunologyRegulatory T CellsVivo ExpansionAutoimmunityHaploidentical DonorsGraft SurvivalCell BiologyImmunotherapyMedicineCell TransplantationGraft Rejection